A comparison of epinephrine and norepinephrine in critically ill patients
JA Myburgh, A Higgins, A Jovanovska, J Lipman… - Intensive care …, 2008 - Springer
Objective To determine whether there was a difference between epinephrine and
norepinephrine in achieving a mean arterial pressure (MAP) goal in intensive care (ICU) …
norepinephrine in achieving a mean arterial pressure (MAP) goal in intensive care (ICU) …
Amidine derived inhibitors of acid-sensing ion channel-3 (ASIC3)
…, RM DiPardo, SP Cook, MJ Cato, A Jovanovska… - Bioorganic & medicinal …, 2009 - Elsevier
Amidine derived inhibitors of acid-sensing ion channel-3 (ASIC3) - ScienceDirect Skip to
main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View …
main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View …
Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1. 7 inhibitors with pain efficacy in mice
…, I Gregan, M Cato, T Filzen, A Jovanovska… - Bioorganic & medicinal …, 2017 - Elsevier
The voltage-gated sodium channel Na v 1.7 is a genetically validated target for the treatment
of pain with gain-of-function mutations in man eliciting a variety of painful disorders and loss …
of pain with gain-of-function mutations in man eliciting a variety of painful disorders and loss …
[HTML][HTML] Thyroid cancer detection rate and associated risk factors in patients with thyroid nodules classified as Bethesda category III
M Mileva, B Stoilovska, A Jovanovska… - Radiology and …, 2018 - sciendo.com
Background. Ultrasound guided fine-needle aspiration (FNA) is a standard procedure for
thyroid nodules management and selecting patients for surgical treatment. Atypia of …
thyroid nodules management and selecting patients for surgical treatment. Atypia of …
Benzoxazolinone aryl sulfonamides as potent, selective Nav1. 7 inhibitors with in vivo efficacy in a preclinical pain model
…, EN Finger, Y Gregan, DA Henze, A Jovanovska… - Bioorganic & medicinal …, 2017 - Elsevier
Studies on human genetics have suggested that inhibitors of the Na v 1.7 voltage-gated
sodium channel hold considerable promise as therapies for the treatment of chronic pain …
sodium channel hold considerable promise as therapies for the treatment of chronic pain …
Synthesis, Structure− Activity Relationship, and Pharmacological Profile of Analogs of The ASIC-3 Inhibitor A-317567
…, SP Cook, MJ Cato, A Jovanovska… - ACS chemical …, 2010 - ACS Publications
The synthesis, structure− activity relationship (SAR), and pharmacological evaluation of
analogs of the acid-sensing ion channel (ASIC) inhibitor A-317567 are reported. It was …
analogs of the acid-sensing ion channel (ASIC) inhibitor A-317567 are reported. It was …
Discovery of Arylsulfonamide Nav1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile
…, M Clements, C Daley, A Jovanovska… - ACS Medicinal …, 2021 - ACS Publications
The voltage-gated sodium channel Nav1. 7 continues to be a high-profile target for the
treatment of various pain afflictions due to its strong human genetic validation. While isoform …
treatment of various pain afflictions due to its strong human genetic validation. While isoform …
Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3)
…, RM DiPardo, SP Cook, MJ Cato, A Jovanovska… - Bioorganic & medicinal …, 2009 - Elsevier
Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3) - ScienceDirect Skip to
main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF …
main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF …
[HTML][HTML] Subcellular localization of microsomal triglyceride transfer protein
LL Swift, MY Zhu, B Kakkad, A Jovanovska… - Journal of lipid …, 2003 - ASBMB
Microsomal triglyceride transfer protein (MTP) is essential for the assembly of apolipoprotein
B-containing lipoproteins. Within the endoplasmic reticulum, it transfers lipid from the …
B-containing lipoproteins. Within the endoplasmic reticulum, it transfers lipid from the …
[HTML][HTML] Clinical significance of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia
A Jovanovska, S Kocheva… - … Journal of Medical …, 2019 - ncbi.nlm.nih.gov
BACKGROUND: Detection of minimal residual disease (MRD) in the early phase of therapy
is the most powerful predictor of relapse risk in children with acute lymphoblastic leukaemia …
is the most powerful predictor of relapse risk in children with acute lymphoblastic leukaemia …